Comparison of Tolerability and Clinical Performance of Two Emulsion-type Artificial Tears

NCT01335126 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-04-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the performance between two emulsion-type artificial tears.

Conditions

  • Dry Eye

Interventions

OTHER

Emulsion type artificial tear

2 types of artificial tears

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY
  • Hom, Milton M., OD, FAAO

    lead INDIV

Principal Investigators

  • Milton M Hom, OD FAAO · Private Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-10-31
Completion
2011-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335126 on ClinicalTrials.gov